nodes	percent_of_prediction	percent_of_DWPC	metapath
Procainamide—BCHE—Triamcinolone—ankylosing spondylitis	0.216	0.894	CbGbCtD
Procainamide—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0257	0.107	CbGbCtD
Procainamide—Lupus erythematosus—Triamcinolone—ankylosing spondylitis	0.0208	0.0299	CcSEcCtD
Procainamide—Hypotensive—Dexamethasone—ankylosing spondylitis	0.0193	0.0277	CcSEcCtD
Procainamide—Hypotensive—Betamethasone—ankylosing spondylitis	0.0193	0.0277	CcSEcCtD
Procainamide—Systemic lupus erythematosus—Triamcinolone—ankylosing spondylitis	0.014	0.0202	CcSEcCtD
Procainamide—Hepatomegaly—Prednisolone—ankylosing spondylitis	0.0119	0.0171	CcSEcCtD
Procainamide—Pericarditis—Methotrexate—ankylosing spondylitis	0.0118	0.017	CcSEcCtD
Procainamide—Hepatomegaly—Triamcinolone—ankylosing spondylitis	0.011	0.0158	CcSEcCtD
Procainamide—Hepatomegaly—Methylprednisolone—ankylosing spondylitis	0.0109	0.0157	CcSEcCtD
Procainamide—Hepatomegaly—Betamethasone—ankylosing spondylitis	0.00994	0.0143	CcSEcCtD
Procainamide—Hepatomegaly—Dexamethasone—ankylosing spondylitis	0.00994	0.0143	CcSEcCtD
Procainamide—Hepatomegaly—Prednisone—ankylosing spondylitis	0.00865	0.0125	CcSEcCtD
Procainamide—Vasculitis—Prednisolone—ankylosing spondylitis	0.00864	0.0124	CcSEcCtD
Procainamide—Vasculitis—Triamcinolone—ankylosing spondylitis	0.00794	0.0114	CcSEcCtD
Procainamide—Vasculitis—Methylprednisolone—ankylosing spondylitis	0.00792	0.0114	CcSEcCtD
Procainamide—Vasculitis—Betamethasone—ankylosing spondylitis	0.00721	0.0104	CcSEcCtD
Procainamide—Vasculitis—Dexamethasone—ankylosing spondylitis	0.00721	0.0104	CcSEcCtD
Procainamide—Pleural effusion—Methotrexate—ankylosing spondylitis	0.00668	0.00962	CcSEcCtD
Procainamide—Vasculitis—Prednisone—ankylosing spondylitis	0.00628	0.00903	CcSEcCtD
Procainamide—Cardiac arrest—Prednisolone—ankylosing spondylitis	0.00582	0.00837	CcSEcCtD
Procainamide—Cardiac failure—Methylprednisolone—ankylosing spondylitis	0.00575	0.00828	CcSEcCtD
Procainamide—Oliguria—Methotrexate—ankylosing spondylitis	0.00555	0.00799	CcSEcCtD
Procainamide—DNMT1—Budesonide—Methylprednisolone—ankylosing spondylitis	0.00553	0.0866	CbGdCrCtD
Procainamide—Psychotic disorder—Methylprednisolone—ankylosing spondylitis	0.00548	0.00789	CcSEcCtD
Procainamide—DNMT1—Budesonide—Dexamethasone—ankylosing spondylitis	0.00545	0.0853	CbGdCrCtD
Procainamide—DNMT1—Budesonide—Betamethasone—ankylosing spondylitis	0.00545	0.0853	CbGdCrCtD
Procainamide—Hepatic enzyme increased—Methotrexate—ankylosing spondylitis	0.00541	0.00779	CcSEcCtD
Procainamide—Cardiac arrest—Triamcinolone—ankylosing spondylitis	0.00535	0.0077	CcSEcCtD
Procainamide—Cardiac arrest—Methylprednisolone—ankylosing spondylitis	0.00534	0.00768	CcSEcCtD
Procainamide—DNMT1—Budesonide—Triamcinolone—ankylosing spondylitis	0.00532	0.0833	CbGdCrCtD
Procainamide—Vasculitis—Methotrexate—ankylosing spondylitis	0.00524	0.00755	CcSEcCtD
Procainamide—Cardiac failure—Betamethasone—ankylosing spondylitis	0.00523	0.00753	CcSEcCtD
Procainamide—Cardiac failure—Dexamethasone—ankylosing spondylitis	0.00523	0.00753	CcSEcCtD
Procainamide—Lethargy—Dexamethasone—ankylosing spondylitis	0.00521	0.0075	CcSEcCtD
Procainamide—Lethargy—Betamethasone—ankylosing spondylitis	0.00521	0.0075	CcSEcCtD
Procainamide—DNMT1—Budesonide—Prednisone—ankylosing spondylitis	0.00505	0.0791	CbGdCrCtD
Procainamide—Psychotic disorder—Betamethasone—ankylosing spondylitis	0.00499	0.00718	CcSEcCtD
Procainamide—Psychotic disorder—Dexamethasone—ankylosing spondylitis	0.00499	0.00718	CcSEcCtD
Procainamide—DNMT1—Budesonide—Prednisolone—ankylosing spondylitis	0.00493	0.0772	CbGdCrCtD
Procainamide—Cardiac arrest—Betamethasone—ankylosing spondylitis	0.00485	0.00699	CcSEcCtD
Procainamide—Cardiac arrest—Dexamethasone—ankylosing spondylitis	0.00485	0.00699	CcSEcCtD
Procainamide—Cardiac failure—Prednisone—ankylosing spondylitis	0.00456	0.00656	CcSEcCtD
Procainamide—Lethargy—Prednisone—ankylosing spondylitis	0.00454	0.00653	CcSEcCtD
Procainamide—Psychotic disorder—Prednisone—ankylosing spondylitis	0.00434	0.00625	CcSEcCtD
Procainamide—Bradycardia—Prednisolone—ankylosing spondylitis	0.00431	0.0062	CcSEcCtD
Procainamide—Cardiac arrest—Prednisone—ankylosing spondylitis	0.00423	0.00608	CcSEcCtD
Procainamide—Hepatic failure—Methotrexate—ankylosing spondylitis	0.00413	0.00595	CcSEcCtD
Procainamide—Bradycardia—Triamcinolone—ankylosing spondylitis	0.00396	0.0057	CcSEcCtD
Procainamide—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.00395	0.00569	CcSEcCtD
Procainamide—Hallucination—Methylprednisolone—ankylosing spondylitis	0.00386	0.00556	CcSEcCtD
Procainamide—Lethargy—Methotrexate—ankylosing spondylitis	0.00379	0.00546	CcSEcCtD
Procainamide—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.0036	0.00519	CcSEcCtD
Procainamide—Bradycardia—Betamethasone—ankylosing spondylitis	0.0036	0.00518	CcSEcCtD
Procainamide—Bradycardia—Dexamethasone—ankylosing spondylitis	0.0036	0.00518	CcSEcCtD
Procainamide—Neutropenia—Prednisone—ankylosing spondylitis	0.00359	0.00517	CcSEcCtD
Procainamide—Hallucination—Dexamethasone—ankylosing spondylitis	0.00351	0.00506	CcSEcCtD
Procainamide—Hallucination—Betamethasone—ankylosing spondylitis	0.00351	0.00506	CcSEcCtD
Procainamide—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.00342	0.00492	CcSEcCtD
Procainamide—Depression—Prednisone—ankylosing spondylitis	0.00342	0.00492	CcSEcCtD
Procainamide—DNMT1—Dexamethasone—Methylprednisolone—ankylosing spondylitis	0.00338	0.053	CbGdCrCtD
Procainamide—DNMT1—Betamethasone—Methylprednisolone—ankylosing spondylitis	0.00338	0.053	CbGdCrCtD
Procainamide—Angioedema—Prednisolone—ankylosing spondylitis	0.00337	0.00485	CcSEcCtD
Procainamide—DNMT1—Dexamethasone—Betamethasone—ankylosing spondylitis	0.00333	0.0522	CbGdCrCtD
Procainamide—DNMT1—Betamethasone—Dexamethasone—ankylosing spondylitis	0.00333	0.0522	CbGdCrCtD
Procainamide—Malaise—Prednisolone—ankylosing spondylitis	0.00332	0.00478	CcSEcCtD
Procainamide—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.00332	0.00478	CcSEcCtD
Procainamide—DNMT1—Betamethasone—Triamcinolone—ankylosing spondylitis	0.00325	0.051	CbGdCrCtD
Procainamide—DNMT1—Dexamethasone—Triamcinolone—ankylosing spondylitis	0.00325	0.051	CbGdCrCtD
Procainamide—Convulsion—Prednisolone—ankylosing spondylitis	0.00319	0.00459	CcSEcCtD
Procainamide—Eosinophilia—Methotrexate—ankylosing spondylitis	0.00318	0.00458	CcSEcCtD
Procainamide—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.00314	0.00453	CcSEcCtD
Procainamide—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.00314	0.00452	CcSEcCtD
Procainamide—Bradycardia—Prednisone—ankylosing spondylitis	0.00313	0.00451	CcSEcCtD
Procainamide—Discomfort—Prednisolone—ankylosing spondylitis	0.0031	0.00446	CcSEcCtD
Procainamide—Angioedema—Triamcinolone—ankylosing spondylitis	0.0031	0.00446	CcSEcCtD
Procainamide—Angioedema—Methylprednisolone—ankylosing spondylitis	0.00309	0.00445	CcSEcCtD
Procainamide—DNMT1—Dexamethasone—Prednisone—ankylosing spondylitis	0.00309	0.0484	CbGdCrCtD
Procainamide—DNMT1—Betamethasone—Prednisone—ankylosing spondylitis	0.00309	0.0484	CbGdCrCtD
Procainamide—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.00308	0.00443	CcSEcCtD
Procainamide—Hallucination—Prednisone—ankylosing spondylitis	0.00306	0.0044	CcSEcCtD
Procainamide—Malaise—Triamcinolone—ankylosing spondylitis	0.00306	0.0044	CcSEcCtD
Procainamide—Malaise—Methylprednisolone—ankylosing spondylitis	0.00305	0.00439	CcSEcCtD
Procainamide—DNMT1—Betamethasone—Prednisolone—ankylosing spondylitis	0.00302	0.0472	CbGdCrCtD
Procainamide—DNMT1—Dexamethasone—Prednisolone—ankylosing spondylitis	0.00302	0.0472	CbGdCrCtD
Procainamide—Neutropenia—Methotrexate—ankylosing spondylitis	0.003	0.00432	CcSEcCtD
Procainamide—Shock—Prednisolone—ankylosing spondylitis	0.00296	0.00426	CcSEcCtD
Procainamide—Convulsion—Triamcinolone—ankylosing spondylitis	0.00294	0.00423	CcSEcCtD
Procainamide—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00293	0.00422	CcSEcCtD
Procainamide—Myalgia—Triamcinolone—ankylosing spondylitis	0.00288	0.00415	CcSEcCtD
Procainamide—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00288	0.00414	CcSEcCtD
Procainamide—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00288	0.00414	CcSEcCtD
Procainamide—Depression—Methotrexate—ankylosing spondylitis	0.00286	0.00411	CcSEcCtD
Procainamide—Flushing—Prednisone—ankylosing spondylitis	0.00285	0.00411	CcSEcCtD
Procainamide—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00285	0.00411	CcSEcCtD
Procainamide—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00285	0.00411	CcSEcCtD
Procainamide—Discomfort—Triamcinolone—ankylosing spondylitis	0.00285	0.0041	CcSEcCtD
Procainamide—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00284	0.00409	CcSEcCtD
Procainamide—Renal failure—Methotrexate—ankylosing spondylitis	0.00281	0.00405	CcSEcCtD
Procainamide—Angioedema—Betamethasone—ankylosing spondylitis	0.00281	0.00404	CcSEcCtD
Procainamide—Angioedema—Dexamethasone—ankylosing spondylitis	0.00281	0.00404	CcSEcCtD
Procainamide—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00278	0.004	CcSEcCtD
Procainamide—Malaise—Dexamethasone—ankylosing spondylitis	0.00277	0.00399	CcSEcCtD
Procainamide—Malaise—Betamethasone—ankylosing spondylitis	0.00277	0.00399	CcSEcCtD
Procainamide—Shock—Triamcinolone—ankylosing spondylitis	0.00272	0.00392	CcSEcCtD
Procainamide—Shock—Methylprednisolone—ankylosing spondylitis	0.00271	0.00391	CcSEcCtD
Procainamide—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.00267	0.00385	CcSEcCtD
Procainamide—Convulsion—Dexamethasone—ankylosing spondylitis	0.00266	0.00383	CcSEcCtD
Procainamide—Convulsion—Betamethasone—ankylosing spondylitis	0.00266	0.00383	CcSEcCtD
Procainamide—Myalgia—Betamethasone—ankylosing spondylitis	0.00262	0.00377	CcSEcCtD
Procainamide—Myalgia—Dexamethasone—ankylosing spondylitis	0.00262	0.00377	CcSEcCtD
Procainamide—Discomfort—Betamethasone—ankylosing spondylitis	0.00259	0.00372	CcSEcCtD
Procainamide—Discomfort—Dexamethasone—ankylosing spondylitis	0.00259	0.00372	CcSEcCtD
Procainamide—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00258	0.00371	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00252	0.00363	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00251	0.00362	CcSEcCtD
Procainamide—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00248	0.00358	CcSEcCtD
Procainamide—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00248	0.00357	CcSEcCtD
Procainamide—Shock—Dexamethasone—ankylosing spondylitis	0.00247	0.00355	CcSEcCtD
Procainamide—Shock—Betamethasone—ankylosing spondylitis	0.00247	0.00355	CcSEcCtD
Procainamide—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00246	0.00354	CcSEcCtD
Procainamide—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00246	0.00354	CcSEcCtD
Procainamide—Angioedema—Prednisone—ankylosing spondylitis	0.00245	0.00352	CcSEcCtD
Procainamide—Malaise—Prednisone—ankylosing spondylitis	0.00241	0.00348	CcSEcCtD
Procainamide—Anorexia—Betamethasone—ankylosing spondylitis	0.00239	0.00344	CcSEcCtD
Procainamide—Anorexia—Dexamethasone—ankylosing spondylitis	0.00239	0.00344	CcSEcCtD
Procainamide—Urticaria—Prednisolone—ankylosing spondylitis	0.00239	0.00344	CcSEcCtD
Procainamide—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00239	0.00343	CcSEcCtD
Procainamide—Hypotension—Betamethasone—ankylosing spondylitis	0.00234	0.00337	CcSEcCtD
Procainamide—Hypotension—Dexamethasone—ankylosing spondylitis	0.00234	0.00337	CcSEcCtD
Procainamide—Convulsion—Prednisone—ankylosing spondylitis	0.00232	0.00334	CcSEcCtD
Procainamide—Chills—Methotrexate—ankylosing spondylitis	0.00231	0.00332	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00229	0.00329	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00229	0.00329	CcSEcCtD
Procainamide—Myalgia—Prednisone—ankylosing spondylitis	0.00228	0.00328	CcSEcCtD
Procainamide—Arthralgia—Prednisone—ankylosing spondylitis	0.00228	0.00328	CcSEcCtD
Procainamide—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00228	0.00328	CcSEcCtD
Procainamide—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00227	0.00327	CcSEcCtD
Procainamide—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00226	0.00325	CcSEcCtD
Procainamide—Discomfort—Prednisone—ankylosing spondylitis	0.00225	0.00324	CcSEcCtD
Procainamide—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00222	0.00319	CcSEcCtD
Procainamide—Urticaria—Triamcinolone—ankylosing spondylitis	0.0022	0.00316	CcSEcCtD
Procainamide—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00219	0.00316	CcSEcCtD
Procainamide—Dysgeusia—Methotrexate—ankylosing spondylitis	0.00219	0.00315	CcSEcCtD
Procainamide—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00219	0.00315	CcSEcCtD
Procainamide—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00218	0.00314	CcSEcCtD
Procainamide—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00218	0.00314	CcSEcCtD
Procainamide—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00218	0.00314	CcSEcCtD
Procainamide—Shock—Prednisone—ankylosing spondylitis	0.00215	0.00309	CcSEcCtD
Procainamide—Anorexia—Prednisone—ankylosing spondylitis	0.00208	0.003	CcSEcCtD
Procainamide—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.00208	0.00299	CcSEcCtD
Procainamide—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00207	0.00298	CcSEcCtD
Procainamide—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00207	0.00298	CcSEcCtD
Procainamide—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00205	0.00295	CcSEcCtD
Procainamide—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00205	0.00295	CcSEcCtD
Procainamide—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00204	0.00293	CcSEcCtD
Procainamide—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00203	0.00293	CcSEcCtD
Procainamide—Malaise—Methotrexate—ankylosing spondylitis	0.00202	0.0029	CcSEcCtD
Procainamide—Urticaria—Betamethasone—ankylosing spondylitis	0.00199	0.00287	CcSEcCtD
Procainamide—Urticaria—Dexamethasone—ankylosing spondylitis	0.00199	0.00287	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00199	0.00287	CcSEcCtD
Procainamide—Dizziness—Prednisolone—ankylosing spondylitis	0.00199	0.00286	CcSEcCtD
Procainamide—Asthenia—Triamcinolone—ankylosing spondylitis	0.00198	0.00286	CcSEcCtD
Procainamide—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00198	0.00286	CcSEcCtD
Procainamide—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00198	0.00286	CcSEcCtD
Procainamide—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00198	0.00286	CcSEcCtD
Procainamide—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00198	0.00286	CcSEcCtD
Procainamide—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00198	0.00285	CcSEcCtD
Procainamide—Pruritus—Triamcinolone—ankylosing spondylitis	0.00196	0.00282	CcSEcCtD
Procainamide—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00195	0.00281	CcSEcCtD
Procainamide—Convulsion—Methotrexate—ankylosing spondylitis	0.00194	0.00279	CcSEcCtD
Procainamide—Myalgia—Methotrexate—ankylosing spondylitis	0.00191	0.00274	CcSEcCtD
Procainamide—Arthralgia—Methotrexate—ankylosing spondylitis	0.00191	0.00274	CcSEcCtD
Procainamide—Decreased appetite—Prednisone—ankylosing spondylitis	0.0019	0.00273	CcSEcCtD
Procainamide—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00189	0.00272	CcSEcCtD
Procainamide—Discomfort—Methotrexate—ankylosing spondylitis	0.00188	0.00271	CcSEcCtD
Procainamide—Confusional state—Methotrexate—ankylosing spondylitis	0.00184	0.00265	CcSEcCtD
Procainamide—Dizziness—Triamcinolone—ankylosing spondylitis	0.00183	0.00263	CcSEcCtD
Procainamide—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00182	0.00263	CcSEcCtD
Procainamide—Feeling abnormal—Prednisone—ankylosing spondylitis	0.0018	0.00259	CcSEcCtD
Procainamide—Asthenia—Betamethasone—ankylosing spondylitis	0.0018	0.00259	CcSEcCtD
Procainamide—Asthenia—Dexamethasone—ankylosing spondylitis	0.0018	0.00259	CcSEcCtD
Procainamide—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00179	0.00257	CcSEcCtD
Procainamide—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00179	0.00257	CcSEcCtD
Procainamide—Nausea—Prednisolone—ankylosing spondylitis	0.00179	0.00257	CcSEcCtD
Procainamide—Pruritus—Betamethasone—ankylosing spondylitis	0.00178	0.00256	CcSEcCtD
Procainamide—Pruritus—Dexamethasone—ankylosing spondylitis	0.00178	0.00256	CcSEcCtD
Procainamide—Vomiting—Triamcinolone—ankylosing spondylitis	0.00176	0.00253	CcSEcCtD
Procainamide—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00175	0.00253	CcSEcCtD
Procainamide—Anorexia—Methotrexate—ankylosing spondylitis	0.00174	0.00251	CcSEcCtD
Procainamide—Urticaria—Prednisone—ankylosing spondylitis	0.00174	0.0025	CcSEcCtD
Procainamide—Body temperature increased—Prednisone—ankylosing spondylitis	0.00173	0.00249	CcSEcCtD
Procainamide—Abdominal pain—Prednisone—ankylosing spondylitis	0.00173	0.00249	CcSEcCtD
Procainamide—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00172	0.00247	CcSEcCtD
Procainamide—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00172	0.00247	CcSEcCtD
Procainamide—Hypotension—Methotrexate—ankylosing spondylitis	0.00171	0.00246	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00166	0.00239	CcSEcCtD
Procainamide—Dizziness—Dexamethasone—ankylosing spondylitis	0.00166	0.00239	CcSEcCtD
Procainamide—Dizziness—Betamethasone—ankylosing spondylitis	0.00166	0.00239	CcSEcCtD
Procainamide—Nausea—Triamcinolone—ankylosing spondylitis	0.00164	0.00236	CcSEcCtD
Procainamide—Nausea—Methylprednisolone—ankylosing spondylitis	0.00164	0.00236	CcSEcCtD
Procainamide—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00161	0.00232	CcSEcCtD
Procainamide—Vomiting—Dexamethasone—ankylosing spondylitis	0.0016	0.0023	CcSEcCtD
Procainamide—Vomiting—Betamethasone—ankylosing spondylitis	0.0016	0.0023	CcSEcCtD
Procainamide—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00159	0.00228	CcSEcCtD
Procainamide—Asthenia—Prednisone—ankylosing spondylitis	0.00157	0.00226	CcSEcCtD
Procainamide—Pruritus—Prednisone—ankylosing spondylitis	0.00155	0.00223	CcSEcCtD
Procainamide—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.0015	0.00217	CcSEcCtD
Procainamide—Diarrhoea—Prednisone—ankylosing spondylitis	0.0015	0.00215	CcSEcCtD
Procainamide—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00149	0.00215	CcSEcCtD
Procainamide—Nausea—Betamethasone—ankylosing spondylitis	0.00149	0.00215	CcSEcCtD
Procainamide—Nausea—Dexamethasone—ankylosing spondylitis	0.00149	0.00215	CcSEcCtD
Procainamide—Urticaria—Methotrexate—ankylosing spondylitis	0.00145	0.00209	CcSEcCtD
Procainamide—Dizziness—Prednisone—ankylosing spondylitis	0.00145	0.00208	CcSEcCtD
Procainamide—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00144	0.00208	CcSEcCtD
Procainamide—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00144	0.00208	CcSEcCtD
Procainamide—Vomiting—Prednisone—ankylosing spondylitis	0.00139	0.002	CcSEcCtD
Procainamide—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00135	0.00194	CcSEcCtD
Procainamide—Asthenia—Methotrexate—ankylosing spondylitis	0.00131	0.00189	CcSEcCtD
Procainamide—Nausea—Prednisone—ankylosing spondylitis	0.0013	0.00187	CcSEcCtD
Procainamide—Pruritus—Methotrexate—ankylosing spondylitis	0.00129	0.00186	CcSEcCtD
Procainamide—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00125	0.0018	CcSEcCtD
Procainamide—Dizziness—Methotrexate—ankylosing spondylitis	0.00121	0.00174	CcSEcCtD
Procainamide—Vomiting—Methotrexate—ankylosing spondylitis	0.00116	0.00167	CcSEcCtD
Procainamide—Nausea—Methotrexate—ankylosing spondylitis	0.00108	0.00156	CcSEcCtD
